Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis

BMJ Open

Volumn 3, Issue 8, 2013, Pages

  Atlantis, Evan ^a,b   Fahey, Paul ^a   Cochrane, Belinda ^a,c   Wittert, Gary ^b   Smith, Sheree ^a,d  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Staff Specialist Respiratory and Sleep Physician   (Australia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; ESTRADIOL; GONADOTROPIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; NANDROLONE DECANOATE; PLACEBO; SEX HORMONE BINDING GLOBULIN; STANOZOLOL; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ANDROGEN THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOPULMONARY FUNCTION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; EXERCISE; GONADOTROPIN BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; META ANALYSIS; MUSCLE STRENGTH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; RESPIRATORY FAILURE; SIDE EFFECT; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; WORKLOAD;

EID: 84885356494     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003127     Document Type: Article

References (48)

1. Vos T, Flaxman AD, Naghavi M, et al Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990? 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96.
2. Cazzola M, MacNee W, Martinez F.J., et al Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-69.
3. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56:880-7. (Pubitemid 32999838)
4. Marin JM, Cote CG, Diaz O, et al Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med 2011;105:916-21.
5. Hamilton AL, Killian KJ, Summers E, et al Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152(6 Pt 1):2021-31.
6. Nici L, Donner C, Wouters E., et al American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413. (Pubitemid 43900715)
7. O'Shea S.D., Taylor NF, Paratz JD Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest 2009;136:1269-83.
8. COPD Working Group. Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis. Ontario Health Technol Assess Ser 2012;12:1-75.
9. Atlantis E, Martin SA, Haren M.T., et al Demographic, physical and lifestyle factors associated with androgen status: the Florey Adelaide Male Ageing Study (FAMAS). Clin Endocrinol (Oxf) 2009;71:261-72.
10. Jankowska EA, Filippatos G, Ponikowska B., et al Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail 2009;15:442-50.
11. Ravaglia G, Forti P, Maioli F., et al Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population. Exp Gerontol 2002;37:701-12. (Pubitemid 34224114)
12. Kaparianos A, Argyropoulou E, Efremidis G., et al Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study. Eur Rev Med Pharmacol Sci 2011;15:1149-57.
13. Karadag F, Ozcan H, Karul A.B., et al Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. Respirology 2007;12:248-53. (Pubitemid 46239399)
14. Laghi F, Adiguzel N, Tobin MJ Endocrinological derangements in COPD. Eur Respir J 2009;34:975-96.
15. Toma M, McAlister FA, Coglianese E.E., et al Testosterone supplementation in heart failure: a meta-analysis. Circ Heart Fail 2012;5:315-21.
16. Pison CM, Cano NJ, Cherion C, et al Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax 2011;66:953-60.
17. Katznelson L, Robinson MW, Coyle C.L., et al Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. Eur J Endocrinol 2006;155:867-75. (Pubitemid 46040626)
18. Pugh PJ, Jones TH, Channer KS Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J 2003;24:909-15. (Pubitemid 36559984)
19. Fernandez-Balsells M.M., Murad MH, Lane M, et al Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95:2560-75.
20. Caminiti G, Volterrani M, Iellamo F., et al Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009;54:919-27.
21. CRD's guidance for undertaking reviews in health care. Centre for Reviews and Dissemination University of York 2008 Published by CRD. 2009.
22. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
23. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
24. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. Cochrane Collaboration 2011. http://wwwcochrane-handbookorg [serial on the Internet].
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
26. Higgins JP, Thompson SG, Deeks J.J., et al Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
27. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. (Pubitemid 34746062)
28. Egger M, Davey Smith G, Schneider M, et al Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
29. Gow SM, Seth J, Beckett GJ Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax 1987;42:520-5. (Pubitemid 17097057)
30. Semple PD, Beastall GH, Watson W.S., et al Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax 1981;36:605-9. (Pubitemid 11054548)
31. Bratel T, Wennlund A, Carlstrom K. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment. Respir Med 2000;94:1221-8. (Pubitemid 32049250)
32. Iqbal F, Michaelson J, Thaler L., et al Declining bone mass in men with chronic pulmonary disease. Contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116:1616-24. (Pubitemid 30012703)
33. Hsu AH, Chen DY, Lee JJ Serum testosterone levels in patients with chronic obstructive pulmonary disease. Tzu Chi Med J 2006;18:113-20+62.
34. Svartberg J, Schirmer H, Medbo A., et al Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromso study. Eur J Epidemiol 2007;22:107-12. (Pubitemid 46457302)
35. Van Vliet M., Spruit MA, Verleden G, et al Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1105-11. (Pubitemid 43066645)
36. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised 2011). 2011 http://www.goldcopd.org/.
37. Casaburi R, Bhasin S, Cosentino L., et al Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:870-8. (Pubitemid 39346482)
38. Creutzberg EC, Wouters EF, Mostert R, et al A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003;124:1733-42. (Pubitemid 37433566)
39. Ferreira IM, Verreschi IT, Nery L.E., et al The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998;114:19-28. (Pubitemid 28337356)
40. Sharma S, Arneja A, McLean L., et al Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron Respir Dis 2008;5:169-76.
41. Svartberg J, Aasebo U, Hjalmarsen A., et al Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med 2004; 98:906-13. (Pubitemid 39069342)
42. Ding EL, Song Y, Malik V.S., et al Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295:1288-99.
43. Brand JS, Van Der Tweel I, Grobbee DE, et al. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2011;40:189-207.
44. Almeida OP, Yeap BB, Hankey G.J., et al Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry 2008;65:283-9. (Pubitemid 351342444)
45. Atlantis E, Fahey P, Cochrane B., et al Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest 2013. [Epub ahead of print] doi:10.1378/chest.12-1911.
46. Almagro P, Cabrera FJ, Diez J, et al Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD. The ESMI study. Chest 2012;142:1126-33.
47. Kupeli E, Ulubay G, Ulasli S.S., et al Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study. Endocrine 2010;38:76-82.
48. Guo W, Wong S, Li M., et al Testosterone plus low-intensity physical training in late life improves functional performance, skeletal muscle mitochondrial biogenesis, and mitochondrial quality control in male mice. PLoS ONE 2012;7:e51180.